Panacea Biotec's Q4 operating profit nearly disappeared
Standalone operating margin was 0.27%, while interest and depreciation pushed the company to a Rs 4.61 cr pre-tax loss.
Filed 20 Aug 2026, 17:31 IST · after market close · Panacea Biotec Ltd (PANACEABIO)
Key takeaways
- Panacea Biotec's standalone operating margin was only 0.27% in Q4FY26, leaving operating profit at Rs 0.30 cr on revenue of Rs 111.12 cr.
- Interest of Rs 6.33 cr and depreciation of Rs 4.18 cr more than offset operating profit, resulting in a pre-tax loss of Rs 4.61 cr.
- A Rs 4.43 cr tax credit narrowed the reported standalone net loss to Rs 0.18 cr, while other income was Rs 5.60 cr.
Price around the results
Operating profit was almost erased in Q4FY26
Panacea Biotec reported standalone revenue of Rs 111.12 cr against expenses of Rs 110.82 cr, leaving only Rs 0.30 cr of operating profit. The resulting 0.27% operating margin indicates that nearly all revenue was absorbed by operating costs. The results were filed after market close.
Finance costs and depreciation drove the pre-tax loss
Interest of Rs 6.33 cr and depreciation of Rs 4.18 cr turned the Rs 0.30 cr operating profit into a Rs 4.61 cr pre-tax loss. Other income of Rs 5.60 cr exceeded operating profit, so reported earnings were not supported by core operations. A Rs 4.43 cr tax credit largely offset the pre-tax loss and brought the net loss to Rs 0.18 cr; the reported tax rate was 96.1%.
Margin was far below the healthcare peer median
Panacea Biotec's 0.27% standalone operating margin was 23.11 percentage points below the 23.38% median among 48 healthcare peers that had reported the same quarter. It ranked first from the bottom on this measure among those reported peers. No sequential or year-on-year comparison is available here, so the quarter's direction cannot be assessed across periods.
Q4FY26 at a glance
Standalone figures as filed with NSE — cross-checked against an independent source.
| Line item | Q4FY26 |
|---|---|
| Revenue | ₹111 cr |
| Other income | ₹6 cr |
| Expenses | ₹111 cr |
| Operating profit | ₹0 cr |
| Operating margin (%) | 0.27% |
| Interest | ₹6 cr |
| Depreciation | ₹4 cr |
| Profit before tax | ₹-5 cr |
| Tax | ₹-4 cr |
| Net profit | ₹-0 cr |
| EPS (₹) | ₹-0.03 |
Operating margin of 0.27% compares with a Healthcare sector median of 23.38% across 48 peers that have reported Q4FY26.
What to watch
- Whether standalone operating margin moves up from 0.27%.
- Whether interest remains below or above the Rs 6.33 cr reported in Q4FY26.
- Whether the tax credit of Rs 4.43 cr recurs or reported tax moves away from the 96.1% rate.